Survival analysis indicated that patients with high SLC40A1 expression had shorter survival times (Fig. 7e), suggesting its association with glioma malignancy and relevance to erianin and REST-related ferroptosis. This evidence concerns the gene SLC40A1 and central nervous system cancer.